UnknownNot Applicable

MuSK Myasthenia 1000 Study

United States1,000 participantsStarted 2023-08-23

Plain-language summary

The MuSK myasthenia gravis 1000 study seeks to collect saliva samples from 1000 subjects with laboratory confirmed diagnosis of MuSK myasthenia to identify genetic variations associated with MuSK MG. The data collected may be used by researchers to gain a better understanding of the cause of MuSK MG and to identify biomarkers and targeted therapy for MuSK MG.

Who can participate

Age range7 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Lab test confirming diagnosis of MuSK myasthenia gravis * Willingness to provide saliva sample via mail or in person Exclusion Criteria: * Inability to provide informed consent * Unwillingness to provide lab results of elevated muscle specific kinase antibody * Unwillingness to provide saliva sample

What they're measuring

GWAS

Timeframe: 2 years

Trial details

NCT IDNCT06259071

SponsorMyasthenia Gravis Rare Disease Network

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2025-08-23

Contact for this trial

Gulsen Oztosun, MD

202-677-6109 musk1000@mfa.gwu.edu

View on ClinicalTrials.gov More Myasthenia Gravis trials